August 20, 2014

The entire external analgesic category is up 6.7%, reaching a base of $486.9 million across total U.S. multi-outlets for the 52 weeks ended June 15, according to IRI data. And Salonpas, with a 10.9% dollar share, is helping to drive that growth with positive sales gains of 28.7% to $52.9 million.

July 30, 2013

Hisamitsu America, the manufacturer of Salonpas, an OTC pain patch that is FDA approved and clinically proven, announced the launch of Salonpas Deep Relieving Gel, a topical analgesic solution.

April 12, 2012

Hisamitsu America on Wednesday announced the company shipped a season's supply of their topical pain treatment Salonpas products to Jeremy Lin, the New York Knicks point guard who recently underwent surgery to repair a chronic meniscus tear in his knee and is expected to be off the court for about six weeks.

March 5, 2012

Hisamitsu America on Monday launched three new analgesic patches, the company stated.

May 19, 2010

Hisamitsu America on Thursday kicked off its “Join the Pain Free Movement” initiative, a media...